David Siefker

1.3k total citations
28 papers, 1.0k citations indexed

About

David Siefker is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, David Siefker has authored 28 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Epidemiology. Recurrent topics in David Siefker's work include Respiratory viral infections research (10 papers), Neonatal Respiratory Health Research (8 papers) and Immune Cell Function and Interaction (5 papers). David Siefker is often cited by papers focused on Respiratory viral infections research (10 papers), Neonatal Respiratory Health Research (8 papers) and Immune Cell Function and Interaction (5 papers). David Siefker collaborates with scholars based in United States, Tanzania and United Kingdom. David Siefker's co-authors include Stephania A. Cormier, Dahui You, Stephen P. Mayfield, Miller Tran, Andrea L. Manuell, John P. DeVincenzo, Tamekia L. Jones, Bishwas Shrestha, Luan D. Vu and Jordy Saravia and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and The Journal of Immunology.

In The Last Decade

David Siefker

28 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Siefker United States 16 461 251 240 228 188 28 1.0k
Huaiyu Zhou China 27 464 1.0× 388 1.5× 751 3.1× 27 0.1× 69 0.4× 73 1.9k
Takahiro Ono Japan 14 272 0.6× 402 1.6× 91 0.4× 51 0.2× 93 0.5× 48 1.3k
Wasim Abbas France 21 399 0.9× 329 1.3× 251 1.0× 39 0.2× 23 0.1× 55 1.3k
Martina Bergant Slovenia 14 233 0.5× 199 0.8× 280 1.2× 129 0.6× 16 0.1× 32 873
Devi Rajan United States 16 222 0.5× 194 0.8× 216 0.9× 11 0.0× 87 0.5× 32 938
Qihui Liu China 16 207 0.4× 102 0.4× 185 0.8× 25 0.1× 40 0.2× 56 919
Sumita Behera United States 10 261 0.6× 90 0.4× 119 0.5× 25 0.1× 103 0.5× 14 672
Fons Cremers Netherlands 14 783 1.7× 75 0.3× 72 0.3× 24 0.1× 57 0.3× 17 1.1k
Seyed Jalal Kiani Iran 13 243 0.5× 90 0.4× 180 0.8× 14 0.1× 128 0.7× 58 1.0k

Countries citing papers authored by David Siefker

Since Specialization
Citations

This map shows the geographic impact of David Siefker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Siefker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Siefker more than expected).

Fields of papers citing papers by David Siefker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Siefker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Siefker. The network helps show where David Siefker may publish in the future.

Co-authorship network of co-authors of David Siefker

This figure shows the co-authorship network connecting the top 25 collaborators of David Siefker. A scholar is included among the top collaborators of David Siefker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Siefker. David Siefker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Siefker, David, Jean‐Michel Guigner, Ralf Schweins, et al.. (2024). Supramolecular Janus Nanocylinders: Controlling Their Characteristics by the Self‐Assembly Process. Macromolecular Rapid Communications. 46(1). e2400492–e2400492. 1 indexed citations
2.
Förster, Sarah, Yeeting E. Chong, David Siefker, et al.. (2023). Development and Characterization of a Novel Neuropilin-2 Antibody for Immunohistochemical Staining of Cancer and Sarcoidosis Tissue Samples. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 42(5). 157–165. 4 indexed citations
3.
Baughman, Robert P., Vis Niranjan, Christoph Burkart, et al.. (2023). Efzofitimod: a novel anti-inflammatory agent for sarcoidosis.. PubMed. 40(1). e2023011–e2023011. 14 indexed citations
4.
5.
Julián, M, David Siefker, Christoph Burkart, et al.. (2021). Late Breaking Abstract - Immunomodulatory protein ATYR1923 disrupts an in vitro model of sarcoid granuloma formation. OA3986–OA3986. 3 indexed citations
6.
Harding, Jeffrey N., David Siefker, Luan D. Vu, et al.. (2020). Altered gut microbiota in infants is associated with respiratory syncytial virus disease severity. BMC Microbiology. 20(1). 140–140. 49 indexed citations
7.
Vu, Luan D., David Siefker, Tamekia L. Jones, et al.. (2019). Elevated Levels of Type 2 Respiratory Innate Lymphoid Cells in Human Infants with Severe Respiratory Syncytial Virus Bronchiolitis. American Journal of Respiratory and Critical Care Medicine. 200(11). 1414–1423. 63 indexed citations
8.
Siefker, David, Luan D. Vu, Dahui You, et al.. (2019). Respiratory Syncytial Virus Disease Severity Is Associated with Distinct CD8+ T-Cell Profiles. American Journal of Respiratory and Critical Care Medicine. 201(3). 325–334. 30 indexed citations
9.
Hijano, Diego R., David Siefker, Bishwas Shrestha, et al.. (2018). Type I Interferon Potentiates IgA Immunity to Respiratory Syncytial Virus Infection During Infancy. Scientific Reports. 8(1). 11034–11034. 33 indexed citations
10.
11.
Siefker, David & Becky Adkins. (2017). Rapid CD8+ Function Is Critical for Protection of Neonatal Mice from an Extracellular Bacterial Enteropathogen. Frontiers in Pediatrics. 4. 141–141. 16 indexed citations
12.
Fitzpatrick, Elizabeth, Dahui You, Bishwas Shrestha, et al.. (2017). A Neonatal Murine Model of MRSA Pneumonia. PLoS ONE. 12(1). e0169273–e0169273. 13 indexed citations
13.
Siefker, David, Robert W. Williams, Lu Lu, Dahui You, & Stephania A. Cormier. (2017). The Influence of Genetic Diversity on Neonatal Respiratory Syncytial Virus Disease. The Journal of Immunology. 198(Supplement_1). 121.8–121.8. 1 indexed citations
14.
You, Dahui, David Siefker, Bishwas Shrestha, Jordy Saravia, & Stephania A. Cormier. (2015). Building a better neonatal mouse model to understand infant respiratory syncytial virus disease. Respiratory Research. 16(1). 91–91. 16 indexed citations
15.
You, Dahui, Jordy Saravia, David Siefker, Bishwas Shrestha, & Stephania A. Cormier. (2015). Crawling with Virus: Translational Insights from a Neonatal Mouse Model on the Pathogenesis of Respiratory Syncytial Virus in Infants. Journal of Virology. 90(1). 2–4. 7 indexed citations
16.
Saravia, Jordy, Dahui You, Bishwas Shrestha, et al.. (2015). Respiratory Syncytial Virus Disease Is Mediated by Age-Variable IL-33. PLoS Pathogens. 11(10). e1005217–e1005217. 132 indexed citations
17.
Tran, Miller, Ryan E. Henry, David Siefker, et al.. (2013). Production of anti‐cancer immunotoxins in algae: Ribosome inactivating proteins as fusion partners. Biotechnology and Bioengineering. 110(11). 2826–2835. 60 indexed citations
18.
Sotolongo, John P., David Siefker, Norman H. Altman, et al.. (2011). Host innate recognition of an intestinal bacterial pathogen induces TRIF-dependent protective immunity. The Journal of Experimental Medicine. 208(13). 2705–2716. 42 indexed citations
19.
Mayfield, Stephen P., Andrea L. Manuell, Stephen S. Chen, et al.. (2007). Chlamydomonas reinhardtii chloroplasts as protein factories. Current Opinion in Biotechnology. 18(2). 126–133. 138 indexed citations
20.
Manuell, Andrea L., Marı́a Verónica Beligni, John H. Elder, et al.. (2007). Robust expression of a bioactive mammalian protein in Chlamydomonas chloroplast. Plant Biotechnology Journal. 5(3). 402–412. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huaiyu Zhou Breakdown of academic impact, for papers by Takahiro Ono Breakdown of academic impact, for papers by Wasim Abbas Breakdown of academic impact, for papers by Martina Bergant Breakdown of academic impact, for papers by Devi Rajan Breakdown of academic impact, for papers by Qihui Liu Breakdown of academic impact, for papers by Sumita Behera Breakdown of academic impact, for papers by Fons Cremers Breakdown of academic impact, for papers by Seyed Jalal Kiani
Rankless by CCL
2026